Profile Details
Jay R Harris, MD

Harvard University

Dana-Faber Cancer Institute

44 Binney Street Dana 1622
Boston, MA 2115 USA
Phone: (617) 632-2291
My Blogs:
My Twitter Hashtags:
Dr. Harris is Professor and Chair of the Department of Radiation Oncology at the Dana-Farber Cancer Institute and the Brigham and Women’s Hospital at Harvard Medical School. He also serves as Residency Program Director for the Harvard Radiation Oncology Program. He graduated from the Stanford University School of Medicine and did his residency at the Joint Center for Radiation Therapy at Harvard Medical School. Dr. Harris’ main research interest has been in the area of breast cancer, with a focus on establishing the most effective and safe radiation treatment for these patients. He helped pioneer the use of breast-conserving therapy for patients with early stage breast cancer. Dr. Harris has been an active member of several professional medical societies, including ASTRO where he served as President and Chairman of the Board of Directors and the American Board of Radiology where he served as Trustee. Dr. Harris has written six books and currently sits on four editorial boards in the oncology field. He is the senior editor of Diseases of the Breast, now in its Fourth Edition.
Cancer Biology, Radiation Oncology
Presented at Events Covering:
, Biology, Cancer Biology, Cataract & Refractive Surgery, Oncology, Surgery
Areas of Interest:
1. The utilization of radiation therapy in the management of breast cancer. My principal research interest is the use of radiation therapy in the multidisciplinary management of breast cancer. In particular, I have been involved in the development and optimization of breast-conserving therapy for patients with invasive breast cancer and ductal carcinoma in situ., This work has involved a series of collaborative studies with radiation oncologists, surgeons, pathologists, radiologists, medical oncologists, and medical geneticists to define the optimal use of a variety of modalities, including radiation therapy. Studies have also included evaluations of radiation therapy after mastectomy to improve survival, and collaborative work with investigators in medical physics to ensure the safest and most effective techniques., 2. The causes of breast cancer recurrence following conservative surgery and radiation therapy for early breast cancer.
General Comments:
BSN Rank: 162 / 2941 (What's this?)
Accomplish Score: 1621
Popularity Score: Unavailable
# in My Circle: 0
# in My Org(s): 1329
We'll Post Your CV for Free!
Speaking/Presenting-Abstract/Poster at Mtg: 3 (40 / 0)
Honors and Awards: 8 (80 / 0)
  • Glenn Robbins Award (2008)
  • Gianni Bonadonna Breast Cancer Award (2008)
  • Gold Medal (2007)
Clinical Trial Activity: 0 (0 / 0)
Grant Support: 0 (0 / 0)
Patents Pending: 0 (0 / 0)
Journal - Editor/Reviewer: 0 (0 / 0)
Peer Reviewed Papers, Books, Chapters: 247 (1482 / 0)
  • The Association Between Biological Subtype and Isolated Regional Nodal Failure After Breast-Conserving Therapy (2010)
  • The Biedenkopf Expert Panel Members. Locoregional treatment of primary breast cancer: consensus recommendations from an International Expert Panel. (2010)
  • Panel members. Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer. (2009)
Pre/Non Reviewed Papers, Proceedings: 0 (0 / 0)
Membership in Professional Societies: 6 (18 / 0)
  • American Society for Therapeutic Radiology and Oncology Program committee (1976 - 1989)
  • Massachusetts Medical Society (1985)
  • American Medical Association (1985)
White Papers: 0 (0 / 0)
Registered on BiotechScienceNews: 1

About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.